Evidence map›Paper›PMID 32133633›Full record

ArticleBritish journal of pharmacology2020

Hispidulin attenuates the social withdrawal in isolated disrupted-in-schizophrenia-1 mutant and chronic phencyclidine-treated mice.

Akihiro Mouri, Hsin-Jung Lee, Takayoshi Mamiya, Yuki Aoyama, Yurie Matsumoto, Hisayoshi Kubota, Wei-Jan Huang, Lih-Chu Chiou, Toshitaka Nabeshima

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Flavonoids fromADMET & DMPK · 2024
    Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Akihiro MouriAdvanced Diagnostic System Research Laboratory, Fujita Health University, Graduate School of Health Sciences, Toyoake, Japan.ORCID 0000-0003-3833-4041
Hsin-Jung LeeDepartment of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.
Takayoshi MamiyaDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Yuki AoyamaDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Yurie MatsumotoDepartment of Chemical Pharmacology, Faculty of Pharmacy, Meijo University, Nagoya, Japan.
Hisayoshi KubotaDepartment of Regulatory Science for Evaluation and Development of Pharmaceuticals and Devices, Fujita Health University, Graduate School of Health Sciences, Toyoake, Japan.
Wei-Jan HuangGraduate Institute of Pharmacognosy, Taipei Medical University, Taipei, Taiwan.
Lih-Chu ChiouDepartment of Pharmacology, College of Medicine, National Taiwan University, Taipei, Taiwan.ORCID 0000-0001-5356-940X
Toshitaka NabeshimaAdvanced Diagnostic System Research Laboratory, Fujita Health University, Graduate School of Health Sciences, Toyoake, Japan.
Fujita Health University · JPMeijo University · JPNational Taiwan University · TWTaipei Medical University · TW

Funding

Japan Society for the Promotion of Science 15K08218Japan Society for the Promotion of Science 16K10195Japan Society for the Promotion of Science 17H04252Japan Society for the Promotion of Science 26460240Meijo Asian Research CenterMinistry of Science and Technology, Taiwan MOST103-2325-B002-037Ministry of Science and Technology, Taiwan MOST104-2325-B002-010Ministry of Science and Technology, Taiwan MOST104-2923-B002-006-MY3Ministry of Science and Technology, Taiwan MOST108-2321-B002-005Ministry of Science and Technology, Taiwan MOST108-2325-B002-029-MY3Ministry of Science and Technology, Taiwan NSC100-2325-B002-050Ministry of Science and Technology, Taiwan NSC101-2325-B002-048Ministry of Science and Technology, Taiwan NSC102-2325-B002-047Nakatomi FoundationNational Health Research Institutes, Taiwan NHRI-EX107-10733NINational Health Research Institutes, Taiwan NHRI-EX108-10733NIPrivate University Research Branding Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)Smoking Research FoundationTakeda Science Foundation
6 · The paper itself

Abstract

background and purposeHispidulin is a flavonoid isolated from Clerodendrum inerme that was found to inhibit intractable motor tics. Previously, we found that hispidulin attenuates hyperlocomotion and the disrupted prepulse inhibition induced by methamphetamine and N-methyl-d-aspartate (NMDA) receptor antagonists, two phenotypes of schizophrenia resembling positive symptoms. Hispidulin can inhibit COMT, a dopamine-metabolizing enzyme in the prefrontal cortex (PFC) that is important for social interaction. Here, we investigated whether hispidulin would affect social withdrawal, one of the negative symptoms of schizophrenia. EXPERIMENTAL APPROACH: We examined whether acute administration of hispidulin would attenuate social withdrawal in two mice models, juvenile isolated disrupted-in-schizophrenia-1 mutant (mutDISC1) mice and chronic phencyclidine (PCP)-treated naïve mice. KEY

resultsIn chronic PCP-treated mice, hispidulin (10 mg·kg CONCLUSIONS AND IMPLICATIONS: Hispidulin attenuated social withdrawal by activating D

Indexed as

FlavonesSchizophreniaAnimalsMicePhencyclidinePrefrontal CortexReceptors, N-Methyl-D-AspartateSocial IsolationFlavoneshispidulinPhencyclidineReceptors, N-Methyl-D-Aspartate

Identifiers

PMID32133633
PMCPMC7312434
OpenAlexW3010190564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.